
Epoch BioDesign is a total bio design company focused on creating a circular economy for plastics and textiles. Their AI-powered biorecycling platform utilizes novel enzymes to break down difficult-to-recycle materials like Nylon and Polyester at low temperatures. This process transforms waste into high-purity outputs, suitable for industries such as apparel, automotive, and packaging, offering a sustainable alternative to virgin materials and reducing carbon footprints. The company integrates AI, synthetic biology, materials science, and process engineering to develop scalable solutions.

Epoch BioDesign is a total bio design company focused on creating a circular economy for plastics and textiles. Their AI-powered biorecycling platform utilizes novel enzymes to break down difficult-to-recycle materials like Nylon and Polyester at low temperatures. This process transforms waste into high-purity outputs, suitable for industries such as apparel, automotive, and packaging, offering a sustainable alternative to virgin materials and reducing carbon footprints. The company integrates AI, synthetic biology, materials science, and process engineering to develop scalable solutions.
Founded: 2019 (London)
Tech: AI-enabled enzyme platform for enzymatic recycling of nylon and polyester
Stage / Funding: Series A announced Mar 5, 2025; ~ $18.3M in Series A; ~ $34M total reported
Scale: Operates multi-tonne production scale with plans for additional sites
| Company |
|---|
Plastic and textile waste recycling; circular materials production
2019
Biotechnology
18.3M
Series A announced Mar 5, 2025; reporting indicates ~ $18.3M for the round.
“Backed by climate/deep-tech investors including Extantia Capital and Lowercarbon Capital; investors include venture firms and government grant participation”